| 17-AAG | 17-(allylamino)-17-demethoxygeldanamycin |
| 17-DMAG | 17-desmethoxy-17-N,N-dimethylaminoethylaminogeldanamycin |
| ADP | adenosine diphosphate |
| Akt | serine-threonine protein kinase |
| AMPK | AMP-activated protein kinase |
| ATP | adenosine triphosphate |
| ATPase | adenosine triphosphatase |
| Bcl-2 | B-cell lymphoma 2 protein |
| BRAF | B-Raf proto-oncogene |
| CTD | C-terminal domain |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| EGCG | epigallocatechin gallate |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial mesenchymal transition |
| EphA2 | ephrin type-A receptor 2 |
| GDA | geldanamycin |
| GRP94 | glucose related protein |
| HER | human epidermal growth factor receptor |
| HIF-1α | hypoxia-inducible factor 1-alpha |
| HSE | heat shock element |
| HSF1 | heat shock factor 1 |
| HSP | heat shock proteins |
| JAK2 | Janus kinase 2 |
| KRAS | K-Ras proto-oncogene |
| MAPK | mitogen-activated protein kinase |
| MCL-1 | induced myeloid leukemia cell differentiation protein |
| MDM2 | mouse double minute 2 homolog |
| MEK | mitogen-activated protein kinase |
| mTOR | mammalian target of rapamycin |
| NBD | nucleotide-binding domain |
| NSCLC | non-small cell lung cancer |
| PAC-1 | procaspase activating compound 1 |
| PES | 2-phenylethynesulfonamide, pifithrin-μ |
| PD-1 | programmed cell death protein 1 |
| PD-L1 | programmed death-ligand 1 |
| pTEFb | positive transcription elongation factor b |
| RDC | radicicol |
| TFIIH | transcription factor II human |
| XPB | xeroderma pigmentosum type B |